epidemiolog
studi
observ
season
peak
incid
influenza
viru
infect
sometim
separ
peak
incid
human
respiratori
syncyti
viru
hrsv
infect
peak
incid
hrsv
infect
delay
propos
due
viral
interfer
wherebi
infect
one
viru
prevent
delay
infect
differ
viru
investig
viral
interfer
hrsv
pandem
influenza
viru
ferret
model
infect
prevent
subsequ
infect
hrsv
infect
hrsv
reduc
morbid
attribut
infect
infect
even
increas
inoculum
dose
hrsv
use
notabl
infect
induc
higher
level
proinflammatori
cytokin
chemokin
immun
mediat
ferret
hrsv
minim
crossreact
serolog
respons
interferon
cell
induc
either
viru
day
infect
data
indic
antigenindepend
mechan
may
drive
viral
interfer
unrel
respiratori
virus
limit
subsequ
infect
diseas
viral
interfer
phenomenon
wherebi
infect
one
viru
limit
delay
infect
second
viru
describ
human
epidemiolog
studi
observ
viral
epidem
peak
vaccin
efficaci
studi
studi
assess
viru
infect
clinic
sampl
anim
studi
vitro
infect
studi
viral
interfer
observ
rang
virus
includ
arbovirus
yellow
fever
dengu
viru
differ
respiratori
virus
influenza
virus
differ
type
subtypeslineag
popul
level
respiratori
viru
infect
may
display
distinct
epidem
peak
observ
studi
netherland
franc
hong
kong
show
emerg
pandem
influenza
viru
delay
infect
human
respiratori
syncyti
viru
hrsv
influenza
viru
infect
also
interrupt
peak
incid
hrsv
infect
japan
netherland
neg
associ
respiratori
virus
report
analyz
proport
coinfect
differ
respiratori
virus
use
swab
specimen
patient
least
like
detect
respiratori
virus
test
includ
hrsv
sampl
age
group
taken
togeth
data
suggest
interfer
may
occur
hrsv
ferret
provid
ideal
model
human
influenza
anim
directli
infect
viru
without
adapt
display
similar
diseas
symptom
human
histor
ferret
also
use
studi
hrsv
infect
recent
studi
assess
pathogenesi
immun
transmiss
hrsv
clinic
symptom
mild
ferret
infect
hrsv
strain
describ
date
previous
use
ferret
model
demonstr
viral
interfer
occur
follow
infect
human
influenza
b
virus
prevent
delay
limit
subsequ
infect
influenza
viru
differ
type
subtyp
lineag
notabl
effect
depend
viru
combin
order
time
sequenti
infect
establish
complementari
influenza
viral
dynam
model
explain
observ
via
innat
immun
respons
crossreact
adapt
immun
respons
ecolog
data
suggest
infect
prevent
delay
infect
hrsv
use
ferret
model
influenza
hrsv
systemat
investig
hypothesi
adult
ferret
hous
peter
doherti
institut
infect
immun
bioresourc
facil
experi
conduct
approv
univers
melbourn
microbiolog
immunolog
anim
ethic
committe
accord
australian
nation
health
medic
research
council
code
practic
care
use
anim
scientif
purpos
ferret
seroneg
antibodi
current
circul
influenza
virus
hrsv
long
strain
use
experi
viru
passag
allanto
embryon
hen
egg
store
infecti
influenza
viru
titer
measur
tissu
cultur
infecti
dose
tcid
assay
read
hemagglutin
turkey
red
blood
cell
hrsv
long
strain
passag
infecti
hrsv
titer
determin
plaqu
assay
ferret
infect
intranas
tcid
plaqueform
unit
pfu
long
hrsv
pfu
long
hrsv
monitor
ferret
hous
pair
infect
group
nasal
wash
specimen
collect
store
day
collect
viral
rna
extract
nasal
wash
specimen
quantit
polymeras
chain
reaction
qpcr
analysi
blood
sampl
obtain
ferret
primari
viru
infect
immedi
day
challeng
serum
isol
proport
chang
weight
calcul
percentag
differ
weight
day
challeng
four
microlit
viral
rna
assay
rtqpcr
hemagglutininspecif
primersprob
cdc
influenza
viru
rtqpcr
influenza
subtyp
panel
obtain
influenza
reagent
resourc
avail
http
wwwinfluenzareagentresourceorg
hrsv
nspecif
primersprob
copi
number
viral
rna
calcul
rel
plasmid
hemagglutinin
copi
number
rsv
rna
calcul
rel
hrsv
rna
standard
mrna
isol
nasal
wash
sampl
mrna
express
cytokin
chemokin
housekeep
gene
quantifi
qpcr
infecti
hrsv
nasal
wash
sampl
measur
use
vs
assay
interferon
enzymelink
immunospot
elispot
assay
cell
detect
ferret
elispotplu
assay
mabtech
singl
cell
suspens
prepar
ferret
retropharyng
lymph
node
total
lymph
node
cell
cultur
without
live
influenza
viru
hrsv
concanavalin
sigma
hour
c
co
titer
antibodi
measur
use
hi
assay
titer
express
reciproc
highest
dilut
serum
hemagglutin
prevent
geometr
mean
titer
gmt
calcul
undetect
titer
express
valu
seroconvers
defin
titer
end
experi
least
rise
baselin
titer
antibodi
neutral
hrsv
long
measur
use
vs
mn
assay
seroconvers
defin
titer
end
experi
increas
least
baselin
titer
antibodi
bind
f
glycoprotein
hrsv
detect
elisa
viral
kinet
assess
viral
rna
nasal
wash
specimen
copi
nasal
wash
posit
correl
replic
viru
base
tcid
assay
level
infecti
viru
measur
transmiss
ferret
hrsv
copi
nasal
wash
correspond
chanc
sampl
posit
virospot
assay
determin
use
probit
regress
model
supplementari
figur
accordingli
sampl
consid
infecti
hrsv
amount
viral
rna
exceed
nasal
wash
infecti
viral
rna
exceed
nasal
wash
least
measur
clinic
sign
ie
weight
loss
fever
assess
daili
seroconvers
measur
day
challeng
statist
analysi
conduct
use
prism
version
unless
otherwis
indic
describ
figur
legend
ferret
first
infect
viru
challeng
hrsv
day
later
vice
versa
figur
interv
inocul
span
time
peak
titer
clearanc
viru
infect
induct
humor
immun
figur
primari
infect
prevent
subsequ
infect
hrsv
ferret
primari
infect
challeng
separ
day
shed
hrsv
minim
singl
ferret
infect
compar
control
anim
figur
ferret
group
seroconvert
hrsv
figur
primari
infect
prevent
infect
hrsv
ferret
infect
separ
day
figur
ferret
shed
viru
seroconvert
figur
ferret
shed
viru
seroconvert
hrsv
figur
prior
infect
prevent
infect
hrsv
day
later
figur
ferret
show
similar
pattern
viru
shed
figur
antibodi
titer
control
anim
receiv
hrsv
alon
figur
kinet
hrsv
shed
examin
anim
protect
hrsv
challeng
peak
hrsv
shed
delay
ferret
infect
follow
hrsv
compar
control
anim
infect
hrsv
alon
median
vs
day
p
mannwhitney
test
figur
chang
durat
viru
shed
figur
clinic
sign
follow
hrsv
challeng
minim
supplementari
figur
consist
previou
studi
ferret
except
control
ferret
infect
hrsv
maintain
gain
weight
supplementari
figur
figur
median
durat
shed
increas
ferret
infect
hrsv
follow
compar
control
anim
infect
alon
vs
day
p
mannwhitney
test
figur
chang
peak
day
shed
figur
prior
infect
hrsv
reduc
diseas
follow
infect
mean
maximum
weight
loss
among
control
ferret
infect
supplementari
figur
mean
maximum
weight
loss
ferret
test
group
n
supplementari
figur
thu
prior
infect
hrsv
significantli
reduc
morbid
measur
weight
loss
challeng
p
mannwhitney
test
fever
detect
follow
infect
supplementari
figur
j
ferret
infect
increas
viral
dose
hrsv
strain
long
altern
hrsv
strain
also
increas
viral
dose
challeng
day
later
laboratoryadapt
strain
shed
similar
level
long
ferret
transmit
cohous
anim
infect
ferret
higher
inoculum
ie
pfu
hrsv
long
led
small
increas
viru
shed
day
infect
compar
anim
infect
pfu
hrsv
long
although
differ
signific
supplementari
figur
primari
infect
pfu
hrsv
long
prevent
infect
infect
separ
day
figur
anim
seroconvert
similar
level
figur
ferret
lost
weight
infect
mean
maximum
weight
loss
among
ferret
infect
alon
wherea
mean
maximum
weight
loss
ferret
n
receiv
primari
infect
hrsv
prior
challeng
p
mannwhitney
test
supplementari
figur
c
differ
fever
supplementari
figur
f
chang
kinet
infect
anim
receiv
prior
hrsv
infect
compar
data
shown
inflamm
induc
viral
infect
may
contribut
viral
interfer
investig
local
immun
respons
follow
infect
hrsv
nasal
wash
specimen
collect
earli
day
later
day
infect
pattern
inflammatori
mediat
chang
throughout
h
hrsv
infect
express
influenza
viru
matrix
mrna
highest
day
infect
wherea
express
hrsv
nucleoprotein
n
mrna
highest
day
figur
two
day
infect
anim
infect
significantli
higher
level
interferon
granzym
b
interleukin
monocyt
chemoattract
protein
tumor
necrosi
factor
mrna
compar
anim
infect
hrsv
figur
express
granzym
mrna
increas
significantli
p
granzym
p
figur
day
infect
level
granzym
close
circl
open
circl
indic
anim
respect
shed
detect
challeng
viru
determin
quantit
reversetranscript
polymeras
chain
reaction
analysi
viral
rna
nasal
wash
nw
sampl
statist
analysi
titer
fold
chang
compar
test
control
group
use
kruskalw
analysi
varianc
dunn
multipl
comparison
test
p
p
c
kinet
shed
analyz
ferret
shed
challeng
viru
figur
data
ferret
obtain
interv
pool
test
group
number
day
challeng
inocul
peak
level
challeng
viru
shed
ci
ciii
number
day
challeng
viru
shed
cii
civ
determin
ferret
indic
group
horizont
line
indic
median
valu
number
day
viru
shed
compar
test
control
group
use
mannwhitney
test
p
p
granzym
b
interleukin
mrna
significantli
higher
anim
infect
compar
infect
hrsv
figur
h
signific
increas
express
interleukin
mrna
day
infect
interleukin
mrna
day
infect
ferret
infect
hrsv
compar
figur
suggest
local
inflammatori
respons
induc
hrsv
infect
coincid
increas
hrsv
viru
replic
figur
directli
compar
magnitud
express
cytokin
chemokin
induc
viru
infect
assess
mrna
express
day
infect
level
viru
shed
highest
ie
day
day
hrsv
assess
time
equival
fold
chang
mrna
express
observ
rsv
n
influenza
viru
figur
infect
induc
significantli
higher
level
p
figur
p
figur
interleukin
p
figur
p
figur
p
figur
mrna
express
ferret
compar
hrsv
data
suggest
increas
inflamm
nasal
tissu
anim
infect
compar
hrsv
differ
express
cytokin
chemokin
ferret
infect
pfu
hrsv
long
data
shown
demonstr
crossreact
cellular
respons
detect
influenza
b
viru
lineag
may
contribut
viral
interfer
thu
assess
whether
cellular
immun
induc
infect
show
crossreact
hrsv
wherea
retropharyng
lymph
node
cell
ferret
restimul
figur
cell
produc
stimul
hrsv
figur
lymph
node
cell
hrsvinfect
ferret
restimul
hrsv
vitro
although
much
lower
level
figur
restimul
figur
respons
concanavalin
similar
ferret
regardless
infect
figur
moreov
limit
serolog
crossreact
anim
infect
high
level
influenza
virusspecif
neutral
antibodi
figur
yet
minim
total
serum
neutral
antibodi
hrsv
figur
similarli
infect
hrsv
induc
total
serum
neutral
antibodi
hrsv
antibodi
reactiv
figur
discuss
demonstr
infect
prevent
infect
replic
hrsv
ferret
model
human
diseas
day
infect
hrsv
prevent
subsequ
infect
rather
anim
coinfect
albeit
reduc
morbid
infect
lead
increas
level
proinflammatori
cytokin
respiratori
tract
compar
infect
hrsv
overal
data
support
ecolog
observ
viral
interfer
induc
infect
delay
infect
hrsv
winter
infect
induc
higher
express
type
ifn
granzym
ab
mrna
compar
hrsv
infect
regul
migrat
macrophagesmonocyt
natur
killer
nk
cell
respiratori
tract
macrophag
produc
thu
upregul
gene
suggest
influx
macrophag
nk
cell
respiratori
tissu
nk
cell
produc
activ
macrophag
neutrophil
promot
tcell
prolifer
kill
virusinfect
cell
cytotox
lymphocyt
nk
cell
also
produc
granzym
ab
increas
express
granzym
ab
mrna
day
infect
suggest
recruitmentactiv
cell
site
infect
type
ifn
produc
respiratori
epitheli
cell
monocytesmacrophag
dendrit
cell
proinflammatori
cytokin
wherea
type
ifn
induc
antivir
state
may
also
limit
replic
spread
hrsv
would
use
explor
cellular
infiltr
follow
hrsv
infect
gain
insight
ferret
infect
plaqueform
unit
pfu
hrsv
strain
long
tissu
cultur
infecti
dose
n
ferretsviru
nasal
wash
specimen
collect
challeng
ferret
day
infect
mrna
assay
indic
gene
use
quantit
polymeras
chain
reaction
qpcr
assay
graph
qpcr
data
express
fold
chang
rel
valu
nasal
wash
specimen
uninfect
anim
normal
gapdh
housekeep
gene
panel
express
n
shown
hrsvinfect
ferret
express
shown
influenza
virusinfect
ferret
statist
analys
inflammatori
mediat
compar
hrsvinfect
anim
sampl
day
infect
hrsvinfect
anim
sampl
day
infect
anim
sampl
day
hrsvinfect
anim
sampl
day
infect
fold
chang
compar
virus
use
mannwhitney
u
test
ifn
interferon
interleukin
interleukin
interleukin
interleukin
interleukin
interleukin
monocyt
chemoattract
protein
tumor
necrosi
factor
p
p
p
p
potenti
differ
level
cellular
composit
present
local
inflamm
infect
induc
higher
cellular
recal
respons
compar
infect
hrsv
studi
signific
differ
respons
concanavalin
group
observ
due
differ
overal
tcell
number
instead
due
increas
reactiv
cell
taken
togeth
data
suggest
infect
induc
robust
cytokin
chemokin
respons
strongli
stimul
adapt
memori
immun
respons
convers
infect
hrsv
elicit
weaker
limit
cytokin
chemokin
respons
led
reduc
antigenspecif
cellular
respons
howev
possibl
hrsv
may
infect
ferret
respiratori
tract
effici
could
result
reduc
inflammatori
respons
yet
infect
anim
seroconvert
titer
consist
steril
immun
indic
product
infect
data
shown
furthermor
increas
inoculum
hrsv
significantli
affect
pattern
amount
viru
shed
express
inflammatori
mediat
suggest
hrsv
level
alreadi
maxim
ferret
model
notabl
increas
express
inflammatori
mediat
follow
infect
influenza
viru
compar
hrsv
observ
studi
assess
human
clinic
sampl
vitro
airway
epitheli
cell
cultur
mechan
viral
interfer
induc
increas
antivir
state
inflamm
observ
infect
potenti
prevent
subsequ
infect
delay
shed
hrsv
observ
virus
predominantli
infect
ciliat
airway
epitheli
cell
shown
hrsv
long
replic
upper
lower
respiratori
tract
ferret
infect
also
prevent
infect
influenza
byamagata
viru
minim
share
epitop
influenza
b
virus
show
minim
crossreact
cell
induc
hrsv
influenza
viru
data
suggest
shortliv
mechan
drive
effect
effect
detect
ferret
one
week
shown
other
mice
infect
separ
day
time
interfer
indic
interact
differ
virus
may
also
import
possibl
differ
mechan
act
differ
viru
combin
gene
express
analysi
earli
marker
immun
respons
cona
b
number
interferon
produc
cell
determin
enzymelink
immunospot
elispot
assay
ce
sera
test
antibodi
hemagglutin
inhibit
hi
assay
c
total
serum
antibodi
bind
hrsv
f
protein
enzymelink
immunosorb
assay
elisa
neutral
serum
antibodi
hrsv
long
virospot
microneutr
mn
assay
e
data
obtain
ferret
per
group
respiratori
epithelium
infect
viru
strain
use
studi
may
provid
insight
notabl
infect
hrsv
reduc
morbid
induc
infect
although
viru
load
decreas
nasal
wash
specimen
viru
shed
may
reduc
lower
respiratori
tract
limit
clinic
diseas
mrna
express
elev
nasal
wash
sampl
ferret
infect
hrsv
compar
increas
express
associ
milder
diseas
ferret
infect
pathogen
influenza
viru
strain
potenti
mediat
rapid
recruit
neutrophil
assist
clear
viru
analysi
lung
influenza
viru
load
anim
infect
hrsv
prior
challeng
would
interest
epidemiolog
data
report
franc
describ
delay
peak
incid
hrsv
infect
follow
emerg
compar
previou
year
similarli
delay
week
expect
peak
hrsv
report
follow
earli
influenza
season
netherland
populationlevel
observ
viral
interfer
aris
interplay
immunodynam
ie
hostlevel
viral
interfer
heterogen
host
ie
differ
immun
viru
strain
individu
transmiss
dynam
ie
within
differ
age
group
influenza
process
investig
detail
other
demonstr
short
period
ie
day
rather
week
viral
interfer
host
level
may
result
substanti
separ
epidem
wave
popul
level
result
provid
first
hostlevel
immunodynam
evid
support
process
drive
epidemiolog
interact
observ
previous
europ
studi
limit
use
circul
strain
earli
laboratori
strain
hrsv
long
long
strain
induc
consist
infect
diseas
ferret
character
cytokin
profil
use
circul
clinic
isol
hrsv
may
provid
morerealist
data
avail
experi
interfer
influenza
viru
hrsv
report
epidemiolog
studi
variou
year
suggest
influenza
virus
may
also
preventlimit
infect
replic
hrsv
current
licens
vaccin
hrsv
identif
hostandor
virusencod
factor
contribut
viral
interfer
provid
platform
facilit
develop
novel
prophylact
therapeut
strategi
prevent
amelior
respiratori
infect
hrsv
infect
signific
burden
commun
especi
among
young
children
